Inventor · disambiguated record
Muralidhara Ramachandra
Also filed as: RAMACHANDRA MURALIDHARA
35 granted patents·19 pending applications·493 citations·filing 1988–2025
97Inventor score
Files withAURIGENE DISCOVERY TECH LTD16SASIKUMAR POTTAYIL GOVINDAN NAIR16AURIGENE ONCOLOGY LTD13CANJI INC3GOSWAMI RAJEEV1
Top patents by PatentIndex Score
54 records- 0198US11465976B21,2,4-oxadiazole and thiadiazole compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Oct 11, 2022·10 cites·30 claims
- 0298US10961205B21,2,4-oxadiazole derivatives as immunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2020·Granted Mar 30, 2021·14 cites·48 claims
- 0397US8907053B2Immunosuppression modulating compoundsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2011·Granted Dec 9, 2014·157 cites·24 claims
- 0496US10781189B21,2,4-Oxadiazole and thiadiazole compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Granted Sep 22, 2020·15 cites·38 claims
- 0596US10590093B21,2,4-oxadiazole derivatives as immunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2018·Granted Mar 17, 2020·17 cites·53 claims
- 0696US9771338B21,2,4-oxadiazole derivatives as immunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2016·Granted Sep 26, 2017·20 cites·47 claims
- 0795US11512060B21,2,4-oxadiazole derivatives as immunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2021·Granted Nov 29, 2022·3 cites·5 claims
- 0895US10173989B21,2,4-oxadiazole derivatives as immunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2017·Granted Jan 8, 2019·17 cites·2 claims
- 0995US9044442B2Peptidomimetic compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2013·Granted Jun 2, 2015·29 cites·17 claims
- 1094US12037321B21,2,4-oxadiazole derivatives as immunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2022·Granted Jul 16, 2024·1 cites·20 claims
- 1194US11865114B2Method for treating diseases using SMARCA2/4 degradersAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Jan 9, 2024·5 cites·46 claims
- 1291US11497734B2Dual inhibitors of TIM-3 and PD-1 pathwaysAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Nov 15, 2022·11 cites·29 claims
- 1390US12064418B2Conjoint therapies for immunomodulationAURIGENE ONCOLOGY LTD·Filed 2022·Granted Aug 20, 2024·2 cites·15 claims
- 1490US12005045B2Method of modulating TIGIT and PD-1 signalling pathways using 1,2,4-oxadiazole compoundsAURIGENE ONCOLOGY LTD·Filed 2023·Granted Jun 11, 2024·1 cites·19 claims
- 1590US11497735B2Conjoint therapies for immunomodulationAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Nov 15, 2022·8 cites·31 claims
- 1688US2024400525A11,2,4-Oxadiazole Derivatives as ImmunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2024·Application pending·0 cites
- 1787US9096642B2Therapeutic compounds for immunomodulationSASIKUMAR POTTAYIL G N·Filed 2011·Granted Aug 4, 2015·29 cites·20 claims
- 1886US9233940B2Cyclic peptidomimetic compounds as immunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2014·Granted Jan 12, 2016·5 cites·10 claims
- 1984US9422339B2Immunomodulating cyclic compoundsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2013·Granted Aug 23, 2016·7 cites·31 claims
- 2084US7001770B1Calpain inhibitors and their applicationsCANJI INC·Filed 1999·Granted Feb 21, 2006·78 cites·19 claims
- 2183US12226402B2Dual inhibitors of TIM-3 and PD-1 pathwaysAURIGENE ONCOLOGY LTD·Filed 2023·Granted Feb 18, 2025·0 cites·14 claims
- 2283US11560403B21,2,4-oxadiazole compounds as inhibitors of CD47 signaling pathwaysAURIGENE ONCOLOGY LTD·Filed 2021·Granted Jan 24, 2023·1 cites·16 claims
- 2381US11274123B21,2,4-oxadiazole compounds as inhibitors of CD47 signallingAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Mar 15, 2022·1 cites·17 claims
- 2478US2023110077A11,2,4-Oxadiazole and Thiadiazole Compounds as ImmunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 2577US5200338ABacterial extracellular lignin peroxidaseIDAHO RESEARCH FOUNDATION INCO·Filed 1988·Granted Apr 6, 1993·21 cites·16 claims
- 2676US11311517B2Combination of small molecule CD-47 inhibitors with other anti-cancer agentsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Apr 26, 2022·2 cites·11 claims
- 2776US10160736B21,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2017·Granted Dec 25, 2018·1 cites·10 claims
- 2876US2024156814A1Method for Treating Diseases Using SMARCA2/4 DegradersAURIGENE ONCOLOGY LTD·Filed 2024·Application pending·0 cites
- 2976US2023062570A1Dual inhibitors of tim-3 and pd-1 pathwaysAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 3074US2025195478A1Dual inhibitors of vista and pd-1 pathwaysAURIGENE ONCOLOGY LTD·Filed 2024·Application pending·0 cites
- 3172US7691370B2Selectivity replicating viral vectorCANJI INC·Filed 2002·Granted Apr 6, 2010·2 cites·16 claims
- 3271US12268670B2Combination of small molecule CD-47 inhibitors with other anti-cancer agentsAURIGENE ONCOLOGY LTD·Filed 2022·Granted Apr 8, 2025·0 cites·21 claims
- 3370US5994134AViral production processCANJI INC·Filed 1998·Granted Nov 30, 1999·33 cites·17 claims
- 3467US2025144082A1Dual inhibitors of tim-3 and pd-1 pathwaysAURIGENE ONCOLOGY LTD·Filed 2025·Application pending·0 cites
- 3564US2025177358A1Combination of small molecule cd-47 inhibitors with other anti-cancer agentsAURIGENE ONCOLOGY LTD·Filed 2025·Application pending·0 cites
- 3661US9776978B21,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2016·Granted Oct 3, 2017·0 cites·55 claims
- 3759US2021379024A1Method of modulating tigit and pd-1 signalling pathways using 1,2,4-oxadiazole compoundsAURIGENE DISCOVERY TECH LTD·Filed 2019·Application pending·0 cites
- 3858US2020061030A1Dual inhibitors of vista and pd-1 pathwaysAURIGENE DISCOVERY TECH LTD·Filed 2017·Application pending·0 cites
- 3958US2016194295A11,3,4-Oxadiazole and 1,3,4-Thiadiazole Derivatives as ImmunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2014·Application pending·0 cites
- 4056US11633394B2Substituted alkynylene compounds as anticancer agentsAURIGENE ONCOLOGY LTD·Filed 2019·Granted Apr 25, 2023·0 cites·30 claims
- 4156US8722930B2Protease inhibitorsGOSWAMI RAJEEV·Filed 2010·Granted May 13, 2014·1 cites·11 claims
- 4256US2023210847A1Substituted Alkynylene Compounds As Anticancer AgentsAURIGENE ONCOLOGY LTD·Filed 2023·Application pending·0 cites
- 4355US2023414605A1Method of Treating Cancer Using FABP5 InhibitorsAURIGENE ONCOLOGY LTD·Filed 2021·Application pending·0 cites
- 4451US10106581B2Cyclic peptidomimetic compounds as immunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2016·Granted Oct 23, 2018·0 cites·6 claims
- 4547US9783578B2Immunosuppression modulating compoundsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2014·Granted Oct 10, 2017·0 cites·22 claims
- 4646US8133481B2Selectively replicating viral vectorsRAMACHANDRA MURALIDHARA·Filed 2010·Granted Mar 13, 2012·0 cites·4 claims
- 4745US2014200225A1Protease inhibitorsORION CORP·Filed 2014·Application pending·0 cites
- 4844US2025339404A1COMBINATION THERAPY USING A CD47-SIRP alpha BLOCKING AGENT AND AZACITIDINEAURIGENE ONCOLOGY LTD·Filed 2025·Application pending·0 cites
- 4943US5232845ABacterial extracellular lignin peroxidaseIDAHO RES FOUND·Filed 1989·Granted Aug 3, 1993·2 cites·16 claims
- 5043US2016113901A1Cyclic Peptidomimetic Compounds as ImmunomodulatorsSASIKUMAR POTTAYIL GOVINDAN NAIR·Filed 2016·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Muralidhara Ramachandra files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →